HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preterm premature rupture of membranes ≥ 32 weeks' gestation: impact of revised practice guidelines.

AbstractOBJECTIVE:
The purpose of this study was to determine the perinatal impact of the 2007 American College of Obstetricians and Gynecologists Practice Bulletin on preterm premature membrane rupture.
STUDY DESIGN:
Perinatal outcomes were compared in women who had experienced preterm membrane rupture in the 3 years before the 2007 Practice Bulletin to similar women who experienced preterm premature rupture of membranes in the 3 years after the issue and implementation of the guideline.
RESULTS:
After adjustment for gestational age at membrane rupture and steroids, composite severe morbidity (death, respiratory distress syndrome, assisted ventilation for ≥ 6 hours, sepsis, pneumonia, grade 3 or 4 intraventricular hemorrhage, or necrotizing enterocolitis) was similar by group. Infants in the "after" group experienced less pneumonia and sepsis, similar respiratory morbidity, but more labor inductions and postpartum hemorrhage.
CONCLUSION:
The new guideline significantly decreases severe neonatal infections but is associated with more frequent labor induction and postpartum hemorrhage.
AuthorsArij Faksh, Joseph R Wax, F Lee Lucas, Angelina Cartin, Michael G Pinette
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 205 Issue 4 Pg. 340.e1-5 (Oct 2011) ISSN: 1097-6868 [Electronic] United States
PMID21784402 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Mosby, Inc. All rights reserved.
Topics
  • Adult
  • Female
  • Fetal Membranes, Premature Rupture (therapy)
  • Gestational Age
  • Guideline Adherence
  • Humans
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Trimester, Third
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: